Tango Therapeutics
TNGX
TNGX
58 hedge funds and large institutions have $741M invested in Tango Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2.57% more ownership
Funds ownership: 74.84% → 77.41% (+2.6%)
12% less capital invested
Capital invested by funds: $844M → $741M (-$103M)
Holders
58
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$10.8M | |
| 2 | +$10.2M | |
| 3 | +$5.86M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.43M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.73M |
Top Sellers
| 1 | -$5.47M | |
| 2 | -$4.59M | |
| 3 | -$3.28M | |
| 4 |
BlackRock
New York
|
-$2.63M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$766K |